# Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial

> **NCT05132712** · EARLY_PHASE1 · UNKNOWN · sponsor: **Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi** · enrollment: 100 (estimated)

## Conditions studied

- Vascular Access Complication

## Interventions

- **DRUG:** Losartan Potassium
- **DRUG:** multi-vitamins

## Key facts

- **NCT ID:** NCT05132712
- **Lead sponsor:** Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-11-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05132712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05132712, "Effects of Angiotensin Converting Enzyme Inhibitors on Patency of Arterio-Venous Fistulas: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT05132712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*